Novavax, Inc. (NVAX) Reports Q2 Loss of $0.04

August 5, 2011 8:08 AM

Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.04), versus ($0.07) reported last year. Revenue for the quarter came in at $3 million versus the consensus estimate of $2.74 million.

No results found